News
KRMD
2.310
0.00%
0.000
Weekly Report: what happened at KRMD last week (0429-0503)?
Weekly Report · 1d ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 5d ago
Craig-Hallum Sticks to Their Buy Rating for REPRO-MED Systems (KRMD)
TipRanks · 5d ago
KORU MEDICAL SYSTEMS <KRMD.O> : CRAIG-HALLUM CUTS TARGET PRICE TO $4 FROM $5
Reuters · 5d ago
REPRO-MED Systems: Strong Start to Fiscal Year 2024 with Strategic Growth and Consistent Margins
TipRanks · 5d ago
KRMD Stock Earnings: KORU Medical Systems Beats EPS, Beats Revenue for Q1 2024
KORU Medical Systems just reported results for the first quarter of 2024. The company reported earnings per share of -2 cents. KORU reported revenue of $8.20 million. This was 9.89% better than the analyst estimate of $7.46 million.
Investorplace · 5d ago
KORU Medical Systems Inc reports results for the quarter ended in January - Earnings Summary
KORU Medical Systems Inc reports results for the quarter ended in January. The company reported a quarterly adjusted loss of 2 cents per share. Revenue rose 10.9% to $8.20 million from a year ago. KORU medical systems Inc shares had fallen by 8.1% this quarter.
Reuters · 5d ago
KORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates
NASDAQ · 5d ago
KORU Medical Systems GAAP EPS of -$0.04 in-line, revenue of $8.2M beats by $0.67M
KORU Medical Systems GAAP EPS of -$0.04 in-line, revenue of $8.2M beats by $0.67M. Reaffirmed full year 2024 revenue guidance of $31.2 million. Sees Cash flow breakeven in the fourth quarter of 2024.
Seeking Alpha · 5d ago
*KORU Medical Systems 1Q Rev $8.2M >KRMD
Dow Jones · 5d ago
*KORU Medical Systems Backs FY24 Rev $31.2M-$32.2M >KRMD
Dow Jones · 5d ago
Press Release: KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth
KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth. First quarter 2024 net revenues of $8.2 million, an 11% increase over the prior year. Core business (U.S. And International) growth of 14% over the first quarter of 2024. Entered a Novel Therapies collaboration with an oncology drug therapy. Company reaffirmed full year 2024 revenue guidance of 10% to 13%.
Dow Jones · 5d ago
Press Release: KORU Medical Systems, Inc. -2-
2023 is the 20th year of the company's existence. The company has a total of $10.7 billion in cash and cash equivalents and $28.2 billion in liabilities. The Company has no debt and no long-term liabilities. The company is expected to be in a position to repay its debt by the end of 2023.
Dow Jones · 5d ago
KORU MEDICAL SYSTEMS INC - QTRLY SHR LOSS $0.04
Reuters · 5d ago
*KORU Medical Systems 1Q Loss/Shr 4c >KRMD
Dow Jones · 5d ago
KORU Medical Systems Inc <KRMD.OQ> expected to post a loss of 4 cents a share - Earnings Preview
KORU Medical Systems Inc expected to post a loss of 4 cents a share - Earnings Preview. The company is expected to show a rise in quarterly revenue when it reports results on May 1 for the period ending March 31 2024. The Mahwah New Jersey-based company expected to report a 1.0% increase in revenue to $7.467 million.
Reuters · 04/29 22:49
Weekly Report: what happened at KRMD last week (0422-0426)?
Weekly Report · 04/29 11:49
Weekly Report: what happened at KRMD last week (0415-0419)?
Weekly Report · 04/22 11:37
Press Release: KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024
KORU Medical Systems to report first quarter 2024 financial results on May 1, 2024. KORU's management will host a conference call and webcast to discuss the financial results and provide a corporate update. The Company is a leading medical technology company focused on innovative and patient-centric large volume subcutaneous infusion solutions.
Dow Jones · 04/17 11:07
KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024
KORU Medical Systems will report first quarter 2024 financial results on Wednesday, May 1, 2024. The Company will host a conference call and webcast to discuss the financial results and provide a corporate update. KORU is a leading medical technology company focused on innovative and patient-centric large volume subcutaneous infusion solutions.
Barchart · 04/17 06:00
More
Webull provides a variety of real-time KRMD stock news. You can receive the latest news about Koru Med Sys through multiple platforms. This information may help you make smarter investment decisions.
About KRMD
KORU Medical Systems, Inc. designs, manufactures, and markets proprietary portable and advanced medical devices primarily for the subcutaneous drug delivery market. The Company is focused on home and specialty infusion solutions. Its focus is primarily concentrated on its mechanical infusion products, the FREEDOM Infusion Systems, which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. The devices are used for infusions administered at home and in alternate care settings. Its infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.